Evidence map›Paper›PMID 37359113›Full record

ArticleJGH open : an open access journal of gastroenterology and hepatology2023

Outcomes of fatty liver disease with and without metabolic comorbidities and risk factors for mortality.

Yuri Ogasawara, Tomomi Kogiso, Kentaro Horiuchi, Makiko Taniai, Katsutoshi Tokushige

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JGH open : an open access journal of gastroenterology and hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuri OgasawaraInstitute of Gastroenterology, Department of Internal Medicine Tokyo Women's Medical University Tokyo Japan.
Tomomi KogisoInstitute of Gastroenterology, Department of Internal Medicine Tokyo Women's Medical University Tokyo Japan.ORCID https://orcid.org/0000-0003-1248-4324
Kentaro HoriuchiInstitute of Gastroenterology, Department of Internal Medicine Tokyo Women's Medical University Tokyo Japan.
Makiko TaniaiInstitute of Gastroenterology, Department of Internal Medicine Tokyo Women's Medical University Tokyo Japan.
Katsutoshi TokushigeInstitute of Gastroenterology, Department of Internal Medicine Tokyo Women's Medical University Tokyo Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aim: As the clinical course of metabolic-associated fatty liver disease (MAFLD) is unclear, we compared the clinical courses of MAFLD and non-alcoholic FLD (NAFLD). Methods: Asian FLD patients ( Results: The N-alone group patients were significantly younger (N alone, M&N, and M alone: 50, 53, and 57 years, respectively), more frequently male (54.3%, 52.6%, and 37.8%), and had a low body mass index (BMI, 23.1, 27.1, and 26.7 kg/m Conclusion: Different risk factors for mortality may exist among the FLD groups.

Indexed as

metabolic‐associated fatty liver diseasemortalitynon‐alcoholic fatty liver disease

Identifiers

PMID37359113
PMCPMC10290268

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.